Raltegravir, also known as Isentress and MK-0518, is a type of medicine called an integrase inhibitor. Integrase inhibitors work by blocking integrase, a protein that HIV needs to insert its viral genetic material into the genetic material of an infected cell. Read More >>
- I've developed resistance to many HIV meds. Will I eventually develop resistance to Isentress, too?
- Is Isentress a good option for HIVers who haven't tried other HIV meds?
- My cholesterol level is very high. Could switching from Norvir (ritonavir) to Isentress reduce my risk of heart disease?
- ICAAC 2007 Study Summaries: An Interview With Joseph Eron, M.D.
Dr. Eron discusses 48-week results of a study of raltegravir (MK-0518) in highly treatment-experienced HIVers. Read More >>
![]() | ||
| Brand Name: |
Isentress |
|
| Generic Name: |
Raltegravir, MK-0518 |
|
| Adult Single Dose: |
One 400-mg tablet twice daily |
|
| Food & Liquid Restrictions: |
None |
|
| Drug Class: |
Integrase Inhibitor |
|
| Patient Information About Isentress >> | ||
![]() | ||








